DDrare: Database of Drug Development for Rare Diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
53	シェーグレン症候群	1

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00426543 (ClinicalTrials.gov)	January 2007	23/1/2007	Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome	Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome	Primary Sjögren's Syndrome;Xerostomia;Hyposalivation;Keratoconjunctivitis Sicca;Fatigue	Drug: MabThera (rituximab);Drug: Rituximab, Mabthera	University of Copenhagen	Rigshospitalet, Denmark	Completed	18 Years	70 Years	Female	21	Phase 2	Denmark

No.

TrialID

Date_
enrollment

Date_
registration

Public_title

Scientific_title

Condition

Intervention

Primary_
sponsor

Secondary_
sponsor

Recruitment_
Status

Inclusion_
agemin

Inclusion_
agemax

Inclusion_
gender

Target_
size

Phase

Countries

January 2007

23/1/2007

Effect of B-cell Depletion in Patients With Primary Sjögren's Syndrome

Phase 1 Study of B-cell Depletion With Rituximab on Oral, Ocular and General Disease Manifestations in Patients With Primary Sjögren's Syndrome

Primary Sjögren's Syndrome;Xerostomia;Hyposalivation;Keratoconjunctivitis Sicca;Fatigue

Drug: MabThera (rituximab);Drug: Rituximab, Mabthera

University of Copenhagen

Rigshospitalet, Denmark

Completed

18 Years

70 Years

Female

Phase 2

Denmark